or Try an Advanced Search...

    Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    GMAB F Genmab A/S 0.00
    APLM F Apollomics Inc. 0.00
    EVAX F Evaxion Biotech A/S 0.00
    PPBT F Purple Biotech Ltd. 0.00
    AGEN F Agenus Inc. 0.00
    LYEL F Lyell Immunopharma, Inc. 0.00
    ADAP F Adaptimmune Therapeutics plc 0.00
    CCCC F C4 Therapeutics, Inc. 0.00
    BCAB F BioAtla, Inc. 0.00
    LCTX F Lineage Cell Therapeutics, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Cancer Clinical Medicine Medicine Biotechnology Acute Myeloid Leukemia Antineoplastic Drugs Breakthrough Therapy Cancer Vaccine Immunotherapies Melanoma Treatment Of Non Small Cell Lung Cancer Vaccination Advanced Cancer Advanced Cancers Advanced Solid Tumors Alzheimer's Disease Amyloid Amyloidosis Antibodies Antibody Drug Conjugate

    Related ETFs - A few ETFs which own one or more of the above listed Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    PBE D PowerShares Dynamic Biotech & Genome 2.78
    OZEM F Roundhill GLP-1 & Weight Loss ETF 1.72
    CNCR F Loncar Cancer Immunotherapy ETF 1.54
    XHE B SPDR S&P Health Care Equipment 1.51
    HTEC D Robo Global Healthcare Technology and Innovation ETF 1.5
    View all Non Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare CNCR to XHE Compare OZEM to XHE Compare PBE to XHE

        Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        Nov 21 GMAB Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?
        Nov 21 APLM Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split
        Nov 20 CCCC C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
        Nov 19 AGEN Agenus (AGEN) Loses -41.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
        Nov 18 EVAX Evaxion Biotech files for offering of ADSs
        Nov 18 AGEN Agenus (AGEN) Loses -41.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
        Nov 16 ADAP Adaptimmune Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 15 GMAB Genmab A/S (GMAB): Among 12 High Growth Large Cap Stocks to Buy Now
        Nov 15 AGEN Down -39.39% in 4 Weeks, Here's Why Agenus (AGEN) Looks Ripe for a Turnaround
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Cancer Clinical Medicine Medicine Biotechnology Acute Myeloid Leukemia Antineoplastic Drugs Breakthrough Therapy Cancer Vaccine Immunotherapies Melanoma Treatment Of Non Small Cell Lung Cancer Vaccination Advanced Cancer Advanced Cancers Advanced Solid Tumors Alzheimer's Disease Amyloid Amyloidosis Antibodies Antibody Drug Conjugate
        Non Small Cell Lung Cancer

        Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. It is a type of cancer that begins in the cells that line the airways of the lungs. NSCLC is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Symptoms of NSCLC include a persistent cough, chest pain, shortness of breath, and coughing up blood. Treatment options for NSCLC include surgery, chemotherapy, radiation therapy, and targeted therapy.

        Browse All Tags